S 1548 · 117th Congress 2021–2023, ended

ENACT Act of 2021

Latest action · May 11, 2021 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 11, 2021
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Equity in Neuroscience and Alzheimer's Clinical Trials Act of 2021 or the ENACT Act of 2021

This bill sets out activities and requirements to increase the participation of underrepresented populations in research and clinical trials for Alzheimer's disease and related dementias.

Specifically, the National Institute on Aging (NIA) must establish and provide technical assistance to Alzheimer's research centers located in areas with higher concentrations of minority groups. These centers must

  • establish diagnostic and treatment clinics designed to serve minority, rural, and other underserved populations;
  • operate clinical trials; and
  • carry out public outreach to encourage members of minority populations to participate in clinical trials and research.

Additionally, the NIA must disseminate information to members of minority populations about participating in clinical trials and take other actions to enhance diversity with respect to the Alzheimer's research that it conducts or supports.

The bill also directs the NIA to increase diversity among Alzheimer's researchers by encouraging the participation of individuals who are from groups that are underrepresented in clinical, behavioral, and social sciences.

Cosponsors 18

Members who signed on, in the order they did. Signatures ran from May 11, 2021 to Sep 12, 2022; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
R-MESusan M. CollinsOriginalMay 11, 2021
D-COMichael F. BennetMay 27, 2021
D-PARobert P. Casey Jr.Jun 17, 2021
I-AZKyrsten SinemaOct 7, 2021
R-KSJerry MoranOct 26, 2021
D-MIDebbie StabenowNov 16, 2021
D-MNTina SmithNov 16, 2021
R-LABill CassidyDec 7, 2021
R-ARJohn BoozmanDec 7, 2021
D-MAEdward J. MarkeyMay 4, 2022
D-MIGary C. PetersMay 4, 2022
R-MSRoger F. WickerMay 10, 2022
R-WVShelley Moore CapitoMay 17, 2022
R-OKJames M. InhofeMay 19, 2022
R-AKLisa MurkowskiMay 19, 2022

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateHealth, Education, Labor, and Pensions Committee
Referred May 11, 2021

Actions 2

Everything that happened, newest first.

  1. May 11, 2021Introduced in Senate
  2. May 11, 2021Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
S. Hrg. 117-55TAKING AIM AT ALZHEIMER'S: FRONTLINE PERSPECTIVES AND CAREGIVER CHALLENGES78 pagesAging (Special) CommitteeMay 20, 2021

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 3085ENACT Act of 2021Identical billMay 12, 2021
S 4486Health Equity and Accountability Act of 2022Related billJun 23, 2022

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to amend the Public Health Service Act to improve the diversity of participants in research on Alzheimer's disease, and for other purposes.
Short Title(s) as Introduced
ENACT Act of 2021
Equity in Neuroscience and Alzheimer’s Clinical Trials Act of 2021

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. May 11, 2021Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.